You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 5,721,244


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,721,244
Title: Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
Abstract:The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments.
Inventor(s): Becker; Reinhard (Wiesbaden, DE), Henning; Rainer (Hattersheim am Main, DE), Ruger; Wolfgang (Kelkheim, DE), Teetz; Volker (Hofheim am Taunus, DE), Urbach; Hans Jorg (Kronberg/Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt an Main, DE)
Application Number:08/483,961
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 5,721,244

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,721,244

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany36 33 496.0Oct 02, 1986

International Family Members for US Patent 5,721,244

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 243083 ⤷  Try a Trial
Austria 402894 ⤷  Try a Trial
Austria 78697 ⤷  Try a Trial
Austria A260087 ⤷  Try a Trial
Australia 611863 ⤷  Try a Trial
Australia 7928087 ⤷  Try a Trial
Canada 1317545 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.